The estimated Net Worth of Leo I Jr Higdon is at least $1.21 Milion dollars as of 8 November 2022. Mr. Higdon owns over 426 units of Encompass Health Corp stock worth over $726,893 and over the last 22 years he sold EHC stock worth over $34,438. In addition, he makes $448,238 as Non-Executive Independent Chairman of the Board at Encompass Health Corp.
Leo has made over 35 trades of the Encompass Health Corp stock since 2007, according to the Form 4 filled with the SEC. Most recently he bought 426 units of EHC stock worth $5,781 on 8 November 2022.
The largest trade he's ever made was exercising 12,295 units of Encompass Health Corp stock on 12 December 2014 worth over $304,670. On average, Leo trades about 855 units every 35 days since 2003. As of 8 November 2022 he still owns at least 7,926 units of Encompass Health Corp stock.
You can see the complete history of Mr. Higdon stock trades at the bottom of the page.
Leo I. Higdon Jr. serves as Non-Executive Independent Chairman of the Board of the Company. Mr. Higdon was unanimously elected to serve as chairman of our board of directors on May 1, 2014. He served as president of Connecticut College from July 1, 2006 to December 31, 2013. He served as the president of the College of Charleston from October 2001 to June 2006. Between 1997 and 2001, Mr. Higdon served as president of Babson College in Wellesley, Massachusetts. He also served as dean of the Darden Graduate School of Business Administration at the University of Virginia. His financial experience includes a 20-year tenure at Salomon Brothers, where he became vice chairman and member of the executive committee, managing the Global Investment Banking Division. Mr. Higdon also serves as the lead independent director of Eaton Vance Corp., a provider of investment management and advisory services, and as a director of Citizens Financial Group, Inc. As a result of his 20 years of experience in the financial services industry combined with his strategic management skills gained through various senior executive positions, including in academia, and service on numerous boards of directors, Mr. Higdon has extensive experience with strategic and financial planning and the operations of large public companies.
As the Non-Executive Independent Chairman of the Board of Encompass Health Corp, the total compensation of Leo Higdon at Encompass Health Corp is $448,238. There are 8 executives at Encompass Health Corp getting paid more, with Mark Tarr having the highest compensation of $7,270,290.
Leo Higdon is 73, he's been the Non-Executive Independent Chairman of the Board of Encompass Health Corp since 2014. There are 1 older and 24 younger executives at Encompass Health Corp. The oldest executive at Encompass Health Corp is L. Edward Shaw, 75, who is the Independent Director.
Leo's mailing address filed with the SEC is 6688 N. CENTRAL EXPRESSWAY, SUITE 1300, DALLAS, TX, 75206.
Over the last 7 years, insiders at Encompass Health Corp have traded over $7,986,642 worth of Encompass Health Corp stock and bought 172,684 units worth $10,417,381 . The most active insiders traders include Greg D Carmichael, L Edward Jr Shaw a Mark J Tarr. On average, Encompass Health Corp executives and independent directors trade stock every 70 days with the average trade being worth of $1,727,816. The most recent stock trade was executed by Douglas E Coltharp on 13 August 2024, trading 12,260 units of EHC stock currently worth $439,276.
as a national leader of post-acute care, encompass health offers facility-based and home-based patient care through our network of inpatient rehabilitation hospitals, home health agencies and hospice agencies. we are committed to delivering high-quality, cost-effective care across the post-acute continuum. driven by a set of shared values, encompass health is the result of the union between healthsouth corporation and encompass home health & hospice.our approach to post-acute care sets us apart. we firmly believe that every success starts with our dedicated team of professionals, so we make sure they are empowered with the tools they need to help our patients be successful. innovative technologies, advanced therapies, customized treatment plans, coordinated care teams – these are all part of our promise to deliver the highest level of care.
Encompass Health Corp executives and other stock owners filed with the SEC include: